How does sharewise work?
Discuss
Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard
Show moreTop Buy/Sell (This Month)
| Security | Price | Target price |
|---|---|---|
| Rheinmetall AG | €1,703.0 | €2,000.0 |
| Amazon.com Inc. | €172.66 | €233.52 |
| ServiceNow Inc. | €84.66 | €185.93 |
| Security | Price | Target price |
|---|---|---|
| Southern Copper | €173.55 | €100.03 |
| Factset Research Systems | €163.00 | €171.09 |
| Mobotix AG | €1.61 | - |
New Top predictions since last week
| Prediction | User | Perf. (%) |
|---|---|---|
| B Ocular Therapeutix Inc. | michaelkr | 35.54% |
| B Ocular Therapeutix Inc. | Jefferies Financial Group Inc. | 24.64% |
| B Ocugen Inc. | PaperHedge66 | 18.92% |
| Prediction | User | Perf. (%) |
|---|---|---|
| S DF Deutsche Forfait AG | Lokrim | -78.85% |
| S DF Deutsche Forfait AG | daimler1 | -78.31% |
| S Coreo AG | Wolf_of_WS | -74.54% |
Many tell you which stocks to buy.
We measure how often they are right!
Portfolios of our members
Mining
When it comes to stocks, what is important for you?
Find stocks based on your criteria with our sharewise stock finder. All results are based on thousands of votes by our community
Pros and Cons of these stocks (New Predictions)
MagForce AG
WKN: A0HGQF / Name: MagForce / Stock / Biotechnology & Medical Research / Small Cap /
Pros
Cons
Nektar Therapeutics
WKN: A419UB / Name: Nektar Therapeutics / Stock / ? /
Pros
Cons
Try sharewise+ and get hundreds more matching stocks
Sign up for free!Tops & Flops S&P 500
| Security | Price | Change(%) (%) |
|---|---|---|
| Paypal Holdings Inc | €37.85 | 7.120% |
| Corning Inc. | €124.52 | 5.170% |
| Discovery Communications C | €22.42 | 5.110% |
| Eli Lilly Corp. | €899.90 | 5.010% |
| Akamai Tech. | €83.96 | 4.880% |
| Security | Price | Change(%) (%) |
|---|---|---|
| Lincoln National | €30.72 | -9.270% |
| Bath & Body Works Inc. | €18.83 | -9.030% |
| Macy's Inc. | €17.36 | -8.690% |
| FMC Corp. | €11.40 | -8.140% |
| American Express Co. | €269.90 | -8.100% |
Courses
sharewise Introduction
Get started on the stock market in these easy steps
Things you will learn:
- What is a stock
- What is a fund
- What is an ETF
- How to open a depot
- How to manage a depot that will regularly beat managed funds
- Why you mostly need patience to succeed on the stock market
Predictions
Top News
These 5 Stocks Are at the Center of the AI Supply Squeeze
Artificial intelligence continues to dominate headlines, boardrooms, and capital markets. And it is not just a buzzword. It is a structural technological shift that is reshaping industries in real
Feeling Bearish? Try These ETFs That Take a Contrarian Approach
The S&P 500 was up about 17% in 2025, but has traded essentially flat so far in 2026, as investors wonder whether a prolonged rally may be about to give way to a major selloff—or whether a
Royal Caribbean Is Cruising Toward a New All-Time High
Amid weakening consumer sentiment and a precarious labor market, the hotel, resort, and cruise line companies in the consumer discretionary sector are not the first place one would think to look
Don’t Try to Catch These 3 Falling Knives
Trying to catch a falling knife can be tempting, especially if it’s a company you know well. Many of the biggest winners over the last 20 years have suffered drawdowns of 40%, 50%, or even 60%
3 Standout ETFs With a Proven Track Record of Success
The world of exchange-traded funds (ETFs) expands and changes at a rapid pace, with investors funneling more than a trillion dollars into these products annually amid a host of new fund launches
Here's What Key Metrics Tell Us About Axsome (AXSM) Q4 Earnings
For the quarter ended December 2025, Axsome Therapeutics (AXSM) reported revenue of $196 million, up 65% over the same period last year. EPS came in at -$0.71, compared to -$0.96 in the year-ago
AMC Entertainment (AMC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
AMC Entertainment (AMC) reported $1.29 billion in revenue for the quarter ended December 2025, representing a year-over-year decline of 1.4%. EPS of -$0.18 for the same period compares to -$0.18 a
Domino's Pizza (DPZ) Reports Q4 Earnings: What Key Metrics Have to Say
For the quarter ended December 2025, Domino's Pizza (DPZ) reported revenue of $1.54 billion, up 6.4% over the same period last year. EPS came in at $5.35, compared to $4.89 in the year-ago quarter.
Veris (VRE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended December 2025, Veris Residential (VRE) reported revenue of $71.31 million, up 4.7% over the same period last year. EPS came in at $0.19, compared to -$0.13 in the year-ago
How to Approach NerdWallet Stock Ahead of Q4 Earnings Release?
NerdWallet, Inc. NRDS is scheduled to release fourth-quarter 2025 earnings on Feb. 25, after the closing bell.
In the third quarter of 2025, NRDS delivered an earnings beat, supported by a robust
Sezzle Gears Up to Report Q4 Earnings: What's in the Offing?
Sezzle Inc. SEZL will release fourth-quarter 2025 results on Feb. 25, after market close.
SEZL has an impressive earnings surprise history. In the four trailing quarters, it surpassed the Zacks
News
Photronics to Report Q1 Earnings: What's in the Cards for the Stock?
Photronics PLAB is set to report its first-quarter fiscal 2026 results on Feb. 25.For the to-be-reported quarter, PLAB expects revenues between $217 million and $225 million. Non-GAAP earnings are
SIFCO Stock Surges 109.7% in Three Months: What's Behind the Rally?
SIFCO Industries, Inc.’s SIF investors have been experiencing some short-term gains from the stock of late. Shares of the Cleveland, OH-based manufacturer of forgings, sub-assemblies and machined
Should Investors Buy RYAAY Post a Bullish Fiscal 2026 Traffic Outlook?
European carrier, Ryanair Holdings RYAAY, has unveiled its raised traffic outlook for fiscal 2026, concurrent with its third-quarter fiscal 2026 earnings release on Jan. 26, 2026. As we know, higher
Is MSFT Stock Vulnerable to Rising Capex Pressure From AI Spending?
Microsoft's MSFT fiscal second-quarter 2026 earnings delivered a familiar combination of strong headline numbers and unsettling fine print, reigniting investor debate over whether the company's
FDA Accepts Roche's NDA Seeking Approval for Breast Cancer Drug
Roche RHHBY announced that the FDA has accepted its new drug application (NDA) for giredestrant, an investigational oral therapy, in combination with everolimus, for the treatment of adult patients
Zoom Video Gears Up to Report Q4 Earnings: How to Play the Stock
Zoom Video Communications ZM is slated to release fourth-quarter fiscal 2026 results on Feb. 25.Zoom expects its fourth-quarter fiscal 2026 revenues to be between $1.23 billion and $1.235 billion
Should Investors Buy, Sell or Hold CRMD Stock Ahead of Q4 Earnings?
We expect investors to focus on the sales performance of CorMedix’s CRMD lead product, DefenCath (taurolidine plus heparin), when the company reports fourth-quarter and full-year 2025 results. The
Adobe Trades 43% Below 52-Week High: Buy, Sell or Hold the Stock?
Adobe ADBE shares closed at $258.61 on Friday, roughly 43% below the 52-week high of $453.26 it hit on March 5, 2025. ADBE shares have plunged 41.8% in the trailing 12-month period, underperforming
Contest
Still running
Heibel Ticker
sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.
Leeway
Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.